129 related articles for article (PubMed ID: 3386825)
1. Treatment response in malignant optic glioma of adulthood.
Albers GW; Hoyt WF; Forno LS; Shratter LA
Neurology; 1988 Jul; 38(7):1071-4. PubMed ID: 3386825
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
3. Visual pathway glioma: an erratic tumour with therapeutic dilemmas.
Shuper A; Horev G; Kornreich L; Michowiz S; Weitz R; Zaizov R; Cohen IJ
Arch Dis Child; 1997 Mar; 76(3):259-63. PubMed ID: 9135269
[TBL] [Abstract][Full Text] [Related]
4. [Leukemic optic neuropathy of an adult case in remission of acute myelocytic leukemia].
Mizorogi F; Suzuki Y; Ohhashi M; Horiguchi M; Mizobuchi T; Horiuchi T
Rinsho Ketsueki; 1987 Nov; 28(11):2068-72. PubMed ID: 3482115
[No Abstract] [Full Text] [Related]
5. Management of low-grade gliomas of the optic nerve and chiasm.
Flickinger JC; Torres C; Deutsch M
Cancer; 1988 Feb; 61(4):635-42. PubMed ID: 3338030
[TBL] [Abstract][Full Text] [Related]
6. Management of optic pathway tumors of childhood.
Wisoff JH
Neurosurg Clin N Am; 1992 Oct; 3(4):791-802. PubMed ID: 1392576
[No Abstract] [Full Text] [Related]
7. The neurosurgical management of optic glioma. Results in 104 patients.
Tenny RT; Laws ER; Younge BR; Rush JA
J Neurosurg; 1982 Oct; 57(4):452-8. PubMed ID: 7108594
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis.
Charrow J; Listernick R; Greenwald MJ; Das L; Radkowski MA
Med Pediatr Oncol; 1993; 21(9):680-4. PubMed ID: 8413004
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma.
Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK
Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391
[TBL] [Abstract][Full Text] [Related]
10. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab is active as a single agent against recurrent malignant gliomas.
Agha CA; Ibrahim S; Hassan A; Elias DA; Fathallah-Shaykh HM
Anticancer Res; 2010 Feb; 30(2):609-11. PubMed ID: 20332478
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic treatment of extensive optic pathway tumors in infants.
Kretschmar CS; Linggood RM
J Neurooncol; 1991 Jun; 10(3):263-70. PubMed ID: 1895167
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitivity testing in the treatment of malignant gliomas.
Darling JL
Prog Exp Tumor Res; 1985; 29():123-30. PubMed ID: 4070628
[No Abstract] [Full Text] [Related]
14. Treating anaplastic oligodendrogliomas and WHO grade 2 gliomas: PCV or temozolomide? The case for PCV.
Levin VA
Oncology (Williston Park); 2015 Apr; 29(4):264, 266-8. PubMed ID: 25952490
[No Abstract] [Full Text] [Related]
15. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
[TBL] [Abstract][Full Text] [Related]
16. [Assessment of procarbazine, vincristine and lomustine association (PCV protocol) in oligodendroglioma and mixed glioma].
Bouffet E; Mornex F; Jouvet A; Thiesse P; Mertens P; Helfre S; Sindou M; Bret P
Bull Cancer; 1997 Oct; 84(10):951-6. PubMed ID: 9435796
[TBL] [Abstract][Full Text] [Related]
17. Low-grade glioma: a challenge in therapeutic options: the role of radiotherapy.
Baumert BG; Stupp R; ;
Ann Oncol; 2008 Sep; 19 Suppl 7():vii217-22. PubMed ID: 18790954
[No Abstract] [Full Text] [Related]
18. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas.
Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642
[TBL] [Abstract][Full Text] [Related]
19. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
20. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
